MCW RES FOUNDATION has a total of 13 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are GRAUPNER GERHART, SYGNIS BIOSCIENCE GMBH & CO KG and IMMUNE SYSTEM KEY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | Australia | 1 | |
#3 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology | |
#4 | Machines | |
#5 | Medical technology | |
#6 | Computer technology | |
#7 | Control |
# | Name | Total Patents |
---|---|---|
#1 | Roman Richard J | 5 |
#2 | Harder David R | 4 |
#3 | Alonso-Galicia Magdalena | 3 |
#4 | Falck John R | 3 |
#5 | Jacobs Elizabeth R | 3 |
#6 | Yahr Timothy L | 2 |
#7 | Sawa Teiji | 2 |
#8 | Frank Dara W | 2 |
#9 | Ulmer John L | 2 |
#10 | Fritz Robert B | 1 |
Publication | Filing date | Title |
---|---|---|
US2006058619A1 | System and method for sensory defect simulation | |
US2006034765A1 | MRI method for measuring tumor hemodynamic parameters in the presence of contrast agent extravasation | |
US2005273001A1 | MRI display interface for medical diagnostics and planning | |
AU9329701A | Phyisological profiling | |
US6395781B1 | 20-HETE antagonists and agonists | |
US6589751B2 | Immonological detection of the homocystamide adduct and a thiolactone immunoassay for endogeneous homocysteine | |
US6183723B1 | Transcobalamin mediated transport of vitamins B12 in intrinsic factor or receptor deficient patient |